Microbial nucleic acids are detected in samples of tissues and blood
from more than 10,000 patients with cancer, and machine learning is used to show
that these can be used to discriminate between and among different types of cancer,
suggesting a new microbiome-based diagnostic approach.
- Gregory D. Poore
- Evguenia Kopylova
- Rob Knight